Article Versions Notes

Nasr M, Saber S, Bazeed AY, Ramadan HA, Ebada A, Ciorba AL, Cavalu S, Elagamy HI. Advantages of Cubosomal Formulation for Gatifloxacin Delivery in the Treatment of Bacterial Keratitis: In Vitro and In Vivo Approach Using Clinical Isolate of Methicillin-Resistant Staphylococcus aureus. Materials. 2022; 15(9):3374. https://doi.org/10.3390/ma15093374

Nasr, Mohamed, Sameh Saber, Alaa Y. Bazeed, Heba A. Ramadan, Asmaa Ebada, Adela Laura Ciorba, Simona Cavalu, and Heba I. Elagamy. 2022. "Advantages of Cubosomal Formulation for Gatifloxacin Delivery in the Treatment of Bacterial Keratitis: In Vitro and In Vivo Approach Using Clinical Isolate of Methicillin-Resistant Staphylococcus aureus" Materials 15, no. 9: 3374. https://doi.org/10.3390/ma15093374

Nasr, M., Saber, S., Bazeed, A. Y., Ramadan, H. A., Ebada, A., Ciorba, A. L., Cavalu, S., & Elagamy, H. I. (2022). Advantages of Cubosomal Formulation for Gatifloxacin Delivery in the Treatment of Bacterial Keratitis: In Vitro and In Vivo Approach Using Clinical Isolate of Methicillin-Resistant Staphylococcus aureus. Materials, 15(9), 3374. https://doi.org/10.3390/ma15093374